Blog

Russ Cohen

Most Popular

Microsoft’s Stock Influence on Retirement Portfolios Assessing Microsoft Stock’s Potential to Help You Retire a Millionaire

Microsoft (NASDAQ: MSFT) stock has made fortunes for numerous shareholders over the last few decades. The company’s ascent toward a remarkable $3 trillion market capitalization has been nothing short of awe-inspiring, culminating in its recent overtaking of Apple as the world’s most valuable business. Undoubtedly, riding this wave has reaped substantial rewards, even for those ...

Russ Cohen

Most Popular

Surge in ETF Inflows for FDN, NFLX, GOOG, ANET

Notable Inflows in FDN Examining the week-over-week shares outstanding changes among ETFs, the First Trust Dow Jones Internet Index Fund (Symbol: FDN) has experienced a significant $148.5 million dollar inflow. This marks a 2.6% increase compared to the previous week, with outstanding units surging from 31,250,002 to 32,050,002. Noteworthy components contributing to this inflow include ...

Russ Cohen

Most Popular

TransCode Therapeutics Shares and Other Stocks Movement The Tumultuous World of Stock Trading: TransCode Therapeutics and Other Stocks in Motion

TransCode Therapeutics’ Plunge Investors witnessed a steep decline in the shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) during the mid-day session on Friday. The company priced a 5,942,623 share common stock offering at $1.22 per share, consequently causing a 24.3% plummet to $0.8248 on the trading charts. Gainers: A Surge in Fortunes Charge Enterprises, Inc. ...

Russ Cohen

Most Popular

Copper Bulls Celebrate Freeport-McMoRan Stock’s Golden Cross Victory Copper Bulls Celebrate Freeport-McMoRan Stock’s Golden Cross Victory

Freeport-McMoRan Inc: A Bullish Triumph Freeport-McMoRan Inc’s stock, trading as FCX, has recently achieved a so-called “golden cross,” with the 50-day Simple Moving Average (SMA) crossing over the 200-day SMA on Jan. 17. This development signals a bullish sentiment in the stock just a week ahead of its fourth-quarter (Q4) earnings report. The 50-day SMA ...

Russ Cohen

Most Popular

The Battle of Cryptos: SEC Meets Coinbase and Binance in the Court The Battle of Cryptos: SEC Meets Coinbase and Binance in the Court

Last summer, the U.S. Securities and Exchange Commission (SEC) sued crypto exchanges Coinbase and Binance, alleging they listed and traded unregistered securities in the form of various cryptocurrencies. This week, the regulator’s legal teams faced the exchanges in court as the companies argued the SEC did not make the case that those cryptos are securities. ...

Russ Cohen

Most Popular

Golden Cross Signals Bullish Momentum for Morgan Stanley After Q4 Earnings Beat Golden Cross Signals Bullish Momentum for Morgan Stanley After Q4 Earnings Beat

Morgan Stanley (MS) stock beat on EPS and revenue as it reported its fourth-quarter earnings on Jan. 16. Buoyed by positive sentiments around the company, the stock just made a remarkable technical move by forming a ‘Golden Cross’ on the price charts. On Jan. 18, the 50-day Simple Moving Average (SMA) for Morgan Stanley stock ...

Russ Cohen

Most Popular

Alibaba Stock Struggles in 2023 The Trials of Alibaba Stock in 2023

Alibaba (NYSE: BABA), the Chinese e-commerce giant, faced a tumultuous year in 2023. It grappled with challenges as the hopes for a Chinese economic recovery faltered, market share eroded, and a plan to spin off non-core businesses suffered a setback due to new U.S. chip export restrictions. Consequently, the stock finished the year down 12%, ...

Russ Cohen

Most Popular

High Volume Trading in Invesco RAFI Strategic US ETF High Volume Trading in Invesco RAFI Strategic US ETF

The trading floor was bustling with fervent activity as the Invesco RAFI Strategic US ETF (IUS) encountered an extraordinary surge in volume during Friday’s afternoon session. An astronomical 333,000 shares were exchanged, a seismic departure from the three-month average volume of a mere 55,000. This unprecedented spike in activity propelled the shares of IUS to ...

Russ Cohen

Most Popular

Jefferies Recommends Buy Rating for Inspire Medical Systems Stock Jefferies Commends Inspire Medical’s Solid Fundamentals and Initiates Buy Rating

monsitj Jefferies recently initiated coverage of Inspire Medical Systems (NYSE:INSP) with a buy rating, emphasizing the company’s solid fundamentals and the anticipated minimal impact from GLP-1 drugs. The analysts’ note expressed confidence in strong underlying strength, driven by increasing Hypoglossal Nerve Stimulation (HGNS) penetration and awareness. They cited label expansion, progress in reducing pre-surgery diagnostic ...